China NMPA Drug Inspection - Qingdao Huanghai Pharmaceutical Co., Ltd. - Nifedipine Extended-Release Tablets (II)
China NMPA drug inspection for Qingdao Huanghai Pharmaceutical Co., Ltd. published July 27, 2017. Drug: Nifedipine Extended-Release Tablets (II). The Hubei Province Drug Quality Announcement, issued on July 27, 2017, reported the findings from drug quality inspectio
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Qingdao Huanghai Pharmaceutical Co., Ltd. published July 27, 2017. Drug: Nifedipine Extended-Release Tablets (II). The Hubei Province Drug Quality Announcement, issued on July 27, 2017, reported the findings from drug quality inspectio
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox